Home

Aetiology

Alzheimer's Disease

Read time: 5 min

Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease?

Amyloid-beta (Aβ) accumulation in Alzheimer’s Disease (AD) may, in part, be due to an...

Alzheimer's Disease

Read time: 5 min

Taking a closer look at tau

Our understanding of tau pathology, a critical component of Alzheimer’s Disease development,...

Alzheimer's Disease

Read time: 4 min

New insights into Apolipoprotein E and Alzheimer’s Disease

Apolipoprotein E4 is a major risk factor for Alzheimer’s Disease and is strongly related to...

Read time: 3 min

Congress highlights

Urgent need to optimize treatment in major depression

Residual symptoms reduce the likelihood of return to pre-depression functioning and increase the...

Read time: 4 min

Congress highlights

Mechanisms underlying clinical manifestations of treatment resistance in schizophrenia

Antipsychotics are not effective in 30% of patients with schizophrenia. These patients have...

Read time: 3 min

Congress highlights

From probiotics to psychobiotics: nutrition, gut and brain

The weight of microbes in our gut is about the same as the weight of our brain. Almost certainly...

Read time: 3 min

Marking time: does lack of change raise more questions than answers?

We urgently need markers that reveal people’s risk of developing PD and, if they already have...

Read time: 3 min

USP30 a valid therapeutic target

The idea that mitochondrial dysfunction is implicated in Parkinson’s Disease is not new, but...

Read time: 3 min

Data drives better categorization of patients

Subtypes of Parkinson’s Disease patients with different risks of progression – and...

Read time: 4 min

Neuronal vulnerability, not being neighbors, underlies synuclein spread

Post mortem evidence and connectome mapping show that the distribution of Lewy pathology does not...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Aging, amyloid and Alzheimer’s Disease

Amyloid-beta (Aβ) burden in cognitively normal older adults increases with age and appears to be...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Unraveling network dysfunction in Alzheimer’s Disease

Amyloid precursor protein/amyloid-beta and tau appear to act together to cause deficits in synaptic...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country